All articles by Robert Barrie

Robert Barrie

Robert Barrie is a news and features reporter for Pharmaceutical Technology. He holds a BSc in Neuroscience and his interests include infectious diseases, weight loss therapies, and health politics. Contact Rob

California startup Protuoso raises $9.5m for “mix-and-match” drug platform

Protuoso Biosciences has secured $9.5m in seed financing to develop its platform which combines multiple therapeutic modalities to target diseases…
EMA recommends approvals for both oral and high-dose pen of Wegovy

Both an oral formulation and a high-dose injectable version of Novo Nordisk’s Wegovy (semaglutide) are edging closer to the European…
Eli Lilly to buy trio of vaccine developers in $3.8bn outlay

Eli Lilly has agreed to buy three vaccine-specialist biotechs in a bolstering of its infectious disease portfolio, continuing the drugmaker’s…
CVC consortium tables $12.4bn bid to delist Italian drugmaker Recordati

One of Italy’s only publicly traded large pharma companies could soon be taken into private ownership, after private equity firm…
Gilead teams up with WHO again to eliminate parasitic tropical disease

Gilead has pledged over 400,000 doses of its antifungal medication to countries affected by a parasitic tropical disease as part…

Podcast: Supply chains, obesity drugs, and patents dominate Q1 earnings trends

With pharma and medtech Q1 earnings season now at a close, some sector areas performed better than others. In this…
Takeda faces $885m hit after landmark pay-for-delay lawsuit verdict

Takeda has been ordered to pay $885m – potentially rising to $2.5bn – after a landmark court case verdict found…
UK government bolsters antiviral supply for hantavirus

The UK has received doses of antiviral medicine favipiravir as a precaution in case hantavirus spreads in the country. The…
Vaccine void means current Ebola outbreak declared international emergency

The World Health Organization (WHO) has declared an outbreak of Ebola disease in Sub-Saharan Africa as a public health emergency…
Biopharma industry endorses Pazdur for FDA commissioner role

With the leadership role of the US Food and Drug Administration (FDA) vacant following Marty Makary’s resignation earlier this week,…